Palisade Bio Announces Completion of Enrollment in LB1148 Dose Optimization Study

2 years ago

Topline data expected in Q3 2023 Carlsbad, CA, July 05, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company”), a…

GRI Bio, Inc. (NASDAQ: GRI) to Participate in the Virtual Investor Summer Spotlight Series

2 years ago

- Live moderated webcast with members of the GRI Bio, Inc. management team on Tuesday, July 11th at 2:00 PM…

Ceapro to Participate in the Virtual Investor Summer Spotlight Series

2 years ago

Live moderated video webcast on Wednesday, July 12th at 1:00 PM ETEDMONTON, Alberta, July 05, 2023 (GLOBE NEWSWIRE) -- Ceapro…

Panavance Therapeutics to Participate in the Virtual Investor Summer Spotlight Series

2 years ago

Live moderated video webcast on Thursday, July 13th at 2:00 PM ETBERWYN, Pa., July 05, 2023 (GLOBE NEWSWIRE) -- Panavance…

Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series

2 years ago

Live moderated video webcast on Thursday, July 13th at 10:00 AM ET TORONTO, ONTARIO, July 05, 2023 (GLOBE NEWSWIRE) --…

AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series

2 years ago

Live moderated video webcast on Wednesday, July 12th at 11:00 AM ETOCALA, Fla., July 05, 2023 (GLOBE NEWSWIRE) -- AIM…

ReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible Beneficiaries

2 years ago

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the…

Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology

2 years ago

• The patent protects additional feature sets of SUPERB’s ultrasound and cooling technology • New patent win is the second U.S.…

Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023

2 years ago

MINNEAPOLIS, July 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the…

F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies

2 years ago

LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- F-star Therapeutics, an invoX company (“F-star”), today announced that it has entered into…